1) Summers C, et al. Neutrophil kinetics in health and disease. Trends in Immunol. 2010 ; 31 : 318-324
2) von Vietinghoff S, et al. Homeostatic regulation of blood neutrophil counts. J Immunol. 2008 ; 181 : 5183-5188
3) 日本血液学会. 造血器腫瘍診療ガイドライン 2018年版補訂版. http://www.jshem.or.jp/gui-hemali/table.html (2021年9月29日アクセス)
4) Jaconson CA, et al. Neutropenia. In : Wintrobe's Clinical Hematology 14th ed. WOLTERS KLUWER, 2019
5) 小林正夫, 他. 自己免疫性好中球減少症 (特集 自己免疫性血液疾患 : 診断と治療の進歩). 日内会誌 2014 ; 103 : 1639-1644
6) NCCN Clinical Practice Guidelines in Oncology, Myelodysplastic Syndromes Version 3. 2021
7) Sakka V, et al. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006 ; 17 : 394-398
8) 町野麻美, 他. ICU入室患者における類白血病反応の検討. 日集中医誌 2016 ; 23 : 666-669
9) Osgood EE. Acute monocytic leukemia as an explanation for "hiatus leukemicus" and "myelomonocytic leukemia". Blood. 1969 ; 33 : 268-273
10) Macintyre EA, et al. Lymphocytosis : is it leukemia and when to treat. Postgrad Med J. 1988 ; 64 : 42-47
11) Winter JN, et al. Lymphocytosis, lymphadenopathy : benign or malignant? Hematology Am Soc Hematol Educ Program. 2015 ; 2015 : 106-110
12) Ebell MH, et al. Does This Patient Have Infectious Mononucleosis? The Rational Clinical Examination Systematic Review. JAMA. 2016 ; 315 : 1502-1509
13) Fazi C, et al. Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals. Cytometry B Clin Cytom. 2010 ; 78 Suppl 1 : S61-S68
14) Carbonetti NH. Pertussis leukocytosis : mechanisms, clinical relevance and treatment. Pathog Dis. 2016 ; 74 : ftw087
15) Hallek M, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 ; 131 : 2745-2760
16) Palmer L, et al. ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features. Int J Lab Hematol. 2015 ; 37 : 287-303
17) Oshimi K. Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias. Intern Med. 2017 ; 56 : 1759-1769
18) George TI. Malignant or benign leukocytosis. Hematology Am Soc Hematol Educ Program. 2012 ; 2012 : 475-484
19) Dunmire SK, et al. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015 ; 390 : 211-240
20) 石井智徳. 膠原病における血球減少症. 日内会誌 2014 ; 103 : 1586-1592
21) Li C, et al. Antilymphocyte antibodies in systemic lupus erythematosus : association with disease activity and lymphopenia. J Immunol Res. 2014 ; 2014 : 672126
22) Symmons DP, et al. Lymphopenia in rheumatoid arthritis. J R Soc Med. 1989 ; 82 : 462-463
23) Fessler J, et al. Lymphopenia in primary Sjogren's syndrome is associated with premature aging of naive CD4+T cells. Reumatology (Oxford). 2021 ; 60 : 588-597
24) Cummins NW, et al. Mechanisms of HIV-associated lymphocyte apoptosis : 2010. Cell Death Dis. 2010 ; 1 : e99
25) Laksono BM, et al. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat commun. 2018 ; 9 : 4944
26) Merekoulias G, et al. Lymphocyte to monocyte ratio as a screening tool for influenza. PLos Curr. 2010 ; 2 : RRN1154
27) Kinloch-de Loes S, et al. Symptomatic primary infection due to human immunodeficiency virus type 1 : review of 31 cases. Clin Infect Dis. 1993 ; 17 : 59-65
28) Lynch DT, et al. How I investigate monocytosis. Int J Lab Hematol. 2018 ; 40 : 107-114
29) Mangaonkar AA, et al. Differential Diagnosis and Workup of Monocytosis : A Systematic Approach to a Common Hematologic Finding. Curr Hematol Malig Rep. 2021 ; 16 : 267-275
30) Shi C, et al. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011 ; 11 : 762-774
31) Dutta P, et al. Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol. 2015 ; 35 : 1066-1070
32) Orazi A, et al. Chronic myelomonocytic leukemia. In : WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. WORLD HEALTH ORGANIZATION, 2017
33) Shomali W, et al. World Health Organization-defined eosinophilic disorders : 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019 ; 94 : 1149-1167
34) Larsen RL, et al. How I investigate Eosinophilia. Int J Lab Hematol. 2019 ; 41 : 153-161
35) Lefevre G, et al. The lymphoid variant of hypereosinophilic syndrome : study of 21 patients with CD3-CD4+aberrant T-cell phenotype. Medicine (Baltimore). 2014 ; 93 : 255-266
36) Furuta S, et al. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int. 2019 ; 68 : 430-436
37) Tsurikisawa N, et al. Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis. Clin Exp Allergy. 2018 ; 48 : 1305-1316
38) Kluin-Nelemans HC, et al. Prognostic impact of eosinophils in mastocytosis : analysis of 2350 patients collected in the ECNM Registry. Leukemia. 2020 ; 34 : 1090-1101
39) Acharya KR, et al. Eosinophil granule proteins : form and function. J Biol Chem. 2014 ; 289 : 17406-17415
40) Feriel J, et al. How I investigate basophilia in daily practice. Int J Lab Hematol. 2020 ; 42 : 237-245
41) Camussi G, et al. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF : monocytes, polymorphonuclear neutrophils and basophils. Immunology. 1981 ; 42 : 191-199
42) Obata K, et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood. 2007 ; 110 : 913-920
43) Tsujimura Y, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity. 2008 ; 28 : 581-589
44) Rastogi V, et al. Flushing Disorders Associated with Gastrointestinal Symptoms : Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. Clin Med Res. 2018 ; 16 : 16-28